Differential treatment effect on measures of neurologic exam, functional impairment and patient self-report in multiple sclerosis

Multiple Sclerosis

Volumn 7, Issue 5, 2001, Pages 335-339

  Hoogervorst, E L J ^a   Kalkers, N F ^a   Van Winsen, L M L ^a   Uitdehaag, B M J ^a   Polman, C H ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

EDSS; Guy's Neurological Disability Scale; Methylprednisolone; MS; MS functional composite

Indexed keywords

METHYLPREDNISOLONE;

ADULT; AGED; ARTICLE; CLINICAL OBSERVATION; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; FATIGUE; FEMALE; FOLLOW UP; FUNCTIONAL DISEASE; HUMAN; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC EXAMINATION; OUTCOMES RESEARCH; SCORING SYSTEM; SELF REPORT; SENSITIVITY AND SPECIFICITY; SPEECH; TREATMENT OUTCOME; TREATMENT PLANNING;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; DISABILITY EVALUATION; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAVENOUS; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NEUROLOGIC EXAMINATION; PATIENT SATISFACTION; TREATMENT OUTCOME;

EID: 0034751251     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/135245801681138040     Document Type: Article

References (20)

1. Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
2. Outcomes assessment in multiple sclerosis clinical trials: A critical analysis
3. Clinical scoring methods for multiple sclerosis
4. Kurtzke scales revisited: The application of psychometric methods to clinical intuition
5. The psychometric properties of clinical rating scales used in multiple sclerosis
6. Development of a multiple sclerosis functional composite as a clinical trial outcome measure
7. Clinical outcomes assessments in multiple sclerosis
8. Recommendations from the national multiple sclerosis society clinical outcomes assessment task force
9. MS Functional Composite: Relation to disease phenotype and disability strata
10. Intrarater and interrater reliability of the MS Functional Composite outcome measure
11. The Guy's Neurological Disability Scale (GNDS): A new disability measure for multiple sclerosis
12. Comparisons of patient self-report, neurologic exam and functional impairment in MS
13. Scale development and Guy's Neurological Disability Scale
14. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
15. Defining the clinical course of multiple sclerosis: Results of an international survey
16. Administration and scoring manual for the Multiple Sclerosis Functional Composite measure (MSFC)
17. EDSS reliability
18. Quantitative measures are more sensitive to worsening neurological function in a prospective multiple sclerosis study
19. Utilization of the MS Functional Composite as an outcome measure in the phase 3 trial of interferon beta-1a (R/Avonex) in secondary progress MS (IMPACT)
20. Effect sizes for interpreting changes in health status